Spinal cage Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

spinal cage

3dmorphic pty ltd - 38161 - spinal cage - a system including a device intended to be implanted into the space of an intervertebral disc that has been partially or totally removed during surgery in order to allow bone fusion between two contiguous vertebral bodies, typically in the treatment of degenerative disc disease (ddd). the interbody fusion cage is intended to maintain the height between vertebral bodies adjacent to the device and support loading during fusion and can be of several different geometric forms. the interbody fusion cage is implanted between the bones of the spine providing mechanical stability and sufficient space for therapeutic spinal bone fusion to occur. this process helps to relieve pressure on pinched nerves and prevents vertebral slipping. bone graft is typically used to help with osseointegration. the interbody fusion device may be made of metal, polymer, or other artificial or biological materials, or it may be a combination of these. fixation screws and devices associated with implantation are included with the device. included devices: off-the-shelf interbody fusion cage with integral fixation, bone fixation screws, integral screw locking cap, biomodel, custom-made interbody fusion cage with integral fixation, virtual surgery plan. the integral screw fixation combined with custom fit is intended to give immediate and long-term stability to the operative level, which is intended to aid the fusion process.

Spinal cage Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

spinal cage

globus medical australia pty ltd - 38161 - spinal cage - sable? expandable spacer is a lumbar interbody fusion device intended for use in patients with degenerative disc disease (ddd) at one or more contiguous levels of the lumbosacral spine (l2-s1). ddd is defined as discogenic back pain with degeneration of the disc confirmed by history and radiographic studies. these patients should be skeletally mature and have had at least six (6) months of non-operative treatment. in addition, these patients may have up to grade 1 spondylolisthesis or retrolisthesis at the involved level(s). the sable? expandable spacer is to be filled with autogenous bone graft material, bone graft extenders, and/or bone graft substitutes. the device is intended to be used with supplemental fixation.

LBEL ULTRA BALM MOISTURIZING PROTECTIVE BALM FOR LIPS SPF 20 NUDE TRANSLUCIDE - BEIGE- octinoxate and zinc oxide lipstick
LBEL Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

lbel ultra balm moisturizing protective balm for lips spf 20 nude translucide - beige- octinoxate and zinc oxide lipstick lbel

ventura corporation ltd - octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51), zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z) - octinoxate 0.075 g in 1 g - - helps prevent sunburn

LEVOCETIRIZINE DIHYDROCHLORIDE tablet, coated Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

levocetirizine dihydrochloride tablet, coated

dr.reddy's laboratories ltd. - levocetirizine dihydrochloride (unii: sod6a38aga) (levocetirizine - unii:6u5ea9rt2o) - levocetirizine dihydrochloride 5 mg - levocetirizine dihydrochloride tablets are indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and children 2 years of age and older. levocetirizine dihydrochloride tablets are indicated for the relief of symptoms associated with perennial allergic rhinitis in adults and children 6 months of age and older. levocetirizine dihydrochloride tablets are indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 months of age and older. the use of levocetirizine dihydrochloride tablets are contraindicated in: - patients with known hypersensitivity to levocetirizine or any of the ingredients of levocetirizine , or to cetirizine. observed reactions range from urticaria to anaphylaxis [see adverse reactions (6.2) ]. - patients with end-stage renal disease (clcr < 10 ml/min) and patients undergoing hemodialysis. - pediatric patients 6 to 11 years of age with impaired renal function [see use in specific p

MORE SAVINGS 50 PERCENT ISOPROPYL RUBBING ALCOHOL WITH WINTERGREEN- isopropyl alcohol liquid Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

more savings 50 percent isopropyl rubbing alcohol with wintergreen- isopropyl alcohol liquid

d.j.h. inc - isopropyl alcohol (unii: nd2m416302) (isopropyl alcohol - unii:nd2m416302) - isopropyl alcohol 50 ml in 100 ml - topical antimicrobial - to decrease germs in minor cuts and scrapes. - helps relieve muscular aches due to exertion. stop use and ask a doctor if - condition persists or get worse.

NEUTROGENA T/SAL THERAPEUTIC- salicylic acid shampoo Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

neutrogena t/sal therapeutic- salicylic acid shampoo

johnson & johnson consumer inc. - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - salicylic acid 30 mg in 1 ml - anti-dandruff, anti-seborrheic dermatitis, anti-psoriasis controls the symptoms of dandruff, seborrheic dermatitis and psoriasis.

SCENT-A-WAY ODOR CONTROL MAX- aluminum zirconium trichlorohydrex gly stick Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

scent-a-way odor control max- aluminum zirconium trichlorohydrex gly stick

vvf kansas services llc - aluminum zirconium trichlorohydrex gly (unii: t27d6t99lh) (aluminum zirconium trichlorohydrex gly - unii:t27d6t99lh) - aluminum zirconium trichlorohydrex gly 12.8 g in 64 g - antiperspirant reduces underarm wetness. do not use on broken skin. stop use if rash or irritation occurs.

PRAZOSIN HYDROCHLORIDE capsule Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

prazosin hydrochloride capsule

a-s medication solutions - prazosin hydrochloride (unii: x0z7454b90) (prazosin - unii:xm03yj541d) - prazosin hydrochloride capsules are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including this drug. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety of pharmacologic classes and

NO7 LIFT AND LUMINATE TRIPLE ACTION SERUM FOUNDATION SUNSCREEN BROAD SPECTRUM SPF 15 LATTE- octinoxate, titanium dioxide cream Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

no7 lift and luminate triple action serum foundation sunscreen broad spectrum spf 15 latte- octinoxate, titanium dioxide cream

bcm cosmetique sas - octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51), titanium dioxide (unii: 15fix9v2jp) (titanium dioxide - unii:15fix9v2jp) - uses - helps prevent sunburn